Inflammatory cytokine expression pathways

Inflammatory cytokine expression pathways represent the integrated network of intracellular signaling cascades, including the NF-κB, JAK-STAT, and MAPK systems, that govern the synthesis and release of pro-inflammatory mediators such as TNF-α, IL-1, and IL-6 (Source: Nature Reviews Immunology, Cytokine signaling in health and disease). These pathways are essential for the host's immune response to pathogens and tissue injury; however, their chronic or dysregulated activation is a primary driver of autoimmune and autoinflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease (Source: NIH, Inflammation). Therapeutic intervention typically involves the use of small molecules like JAK inhibitors or corticosteroids that target specific nodes within these cascades to suppress the transcriptional output of inflammatory genes. While effective at reducing systemic inflammation, broad inhibition of these pathways carries significant risks, most notably an increased susceptibility to serious infections due to impaired immune surveillance (Source: FDA, Safety Communications for JAK Inhibitors). This entry is classified as incorrect because it describes a broad biological process rather than a single molecular therapeutic target.

Other names

Pro-inflammatory signaling pathwaysCytokine production pathwaysInflammatory signaling cascadesCytokine gene expression networks

Inhibition of intracellular signaling transducers, such as Janus kinases (JAKs), or transcription factors, such as NF-κB, to prevent the nuclear translocation and subsequent transcription of pro-inflammatory cytokine genes (Source: StatPearls, JAK-STAT Signaling Pathway).